Source: International Congress 2015 – PG8 Airway and lung fibrosis



Rating:

Share or cite this content

Citations should be made in the following way:
Ivana V. Yang (Denver, United States of America). MicroRNAs in the pathogenesis of pulmonary fibrosis. International Congress 2015 – PG8 Airway and lung fibrosis

Member's Comments

No comment yet.

Related content which might interest you: MicroRNAs and pulmonary hypertension Source: Eur Respir J 2014; 43: 313-314 Year: 2004 MicroRNAs in serum of Interstitial lung diseases patients. Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 The role of viruses in the pathogenesis of pulmonary fibrosis Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease Year: 2021 Role of midkine in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Fibulin-1 is a novel biomarker of disease severity in pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Novel biomarkers in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Angiogenesis in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 IGFBP-2 a new interesting target in IPF Source: International Congress 2016 – ILD pathogenesis Year: 2016 The role of miR-21 and miR-34a in the fibrotic process of the lung Source: International Congress 2016 – IPF pathogenesis Year: 2016 Possible target genes in idiopathic pulmonary fibrosis Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases Year: 2007 Cytokines in pathogenesis of pulmonary tuberculosis Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011 Circulating microRNA signature and its novel involvement in pathogenesis of chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Pulmonary expression of alternatively spliced tissue factor as a potential prognostic marker in idiopathic pulmonary fibrosis Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 MiR-214-3p, a new fibromiR involved in the pathogenesis of idiopathic pulmonary fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Potential new biomarkers for idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 102s Year: 2006